Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer’s disease

2015 ◽  
Vol 36 (5) ◽  
pp. 1792-1807 ◽  
Author(s):  
Songwei Duan ◽  
Xiaoyin Guan ◽  
Runxuan Lin ◽  
Xincheng Liu ◽  
Ying Yan ◽  
...  
Brain ◽  
2014 ◽  
Vol 137 (3) ◽  
pp. 887-903 ◽  
Author(s):  
Ajeet Rijal Upadhaya ◽  
Irina Kosterin ◽  
Sathish Kumar ◽  
Christine A. F. von Arnim ◽  
Haruyasu Yamaguchi ◽  
...  

2014 ◽  
Vol 40 (3) ◽  
pp. 643-657 ◽  
Author(s):  
Eva Ramos-Fernández ◽  
Marta Tajes ◽  
Ernest Palomer ◽  
Gerard ILL-Raga ◽  
Mònica Bosch-Morató ◽  
...  

2019 ◽  
Vol 11 (6) ◽  
pp. 901-925 ◽  
Author(s):  
Safura Jokar ◽  
Saeedeh Khazaei ◽  
Hossein Behnammanesh ◽  
Amir Shamloo ◽  
Mostafa Erfani ◽  
...  

2020 ◽  
Vol 8 (26) ◽  
pp. 5776-5782 ◽  
Author(s):  
Yueling Xu ◽  
Lehui Xiao

The aggregation of amyloid-β (Aβ) peptides is closely related to Alzheimer's disease (AD). These functionalized Pdots manifest effective photo-triggered suppression ability for the Aβ aggregation and cytotoxicity under irradiation.


Sign in / Sign up

Export Citation Format

Share Document